# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-007908
Filing Date
2025-02-21
Accepted
2025-02-21 17:01:58
Documents
75
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 2143940
2 |  | ex23-1.htm | EX-23.1 | 3166
3 |  | ex31-1.htm | EX-31.1 | 19374
4 |  | ex31-2.htm | EX-31.2 | 19238
5 |  | ex32-1.htm | EX-32.1 | 5616
6 |  | ex32-2.htm | EX-32.2 | 5680
7 |  | form10-k_001.jpg | GRAPHIC | 66302
8 |  | form10-k_002.jpg | GRAPHIC | 79269
9 |  | form10-k_003.jpg | GRAPHIC | 17189
10 |  | form10-k_004.jpg | GRAPHIC | 33919
11 |  | form10-k_005.jpg | GRAPHIC | 52578
12 |  | form10-k_006.jpg | GRAPHIC | 53141
| Complete submission text file | 0001493152-25-007908.txt |  | 8539632

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL SCHEMA FILE | gtbp-20241231.xsd | EX-101.SCH | 43601
14 | XBRL CALCULATION FILE | gtbp-20241231_cal.xml | EX-101.CAL | 44358
15 | XBRL DEFINITION FILE | gtbp-20241231_def.xml | EX-101.DEF | 190679
16 | XBRL LABEL FILE | gtbp-20241231_lab.xml | EX-101.LAB | 417477
17 | XBRL PRESENTATION FILE | gtbp-20241231_pre.xml | EX-101.PRE | 330091
77 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1212384

Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40023 | Film No.: 25652918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)